Agenus Inc. (AGEN)
USD 1.42
(-8.97%)
USD 1.42
(-8.97%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -245.76 Million USD | 9.49% |
| 2022 | -271.51 Million USD | -186.72% |
| 2021 | -94.69 Million USD | 60.57% |
| 2020 | -240.13 Million USD | -61.02% |
| 2019 | -149.13 Million USD | 6.61% |
| 2018 | -159.69 Million USD | -32.31% |
| 2017 | -120.69 Million USD | 4.96% |
| 2016 | -126.99 Million USD | -44.51% |
| 2015 | -87.88 Million USD | -106.85% |
| 2014 | -42.48 Million USD | -41.28% |
| 2013 | -30.07 Million USD | -165.55% |
| 2012 | -11.32 Million USD | 51.35% |
| 2011 | -23.27 Million USD | -6.25% |
| 2010 | -21.9 Million USD | 27.74% |
| 2009 | -30.31 Million USD | -5.65% |
| 2008 | -28.69 Million USD | 22.01% |
| 2007 | -36.79 Million USD | 29.08% |
| 2006 | -51.88 Million USD | 29.99% |
| 2005 | -74.1 Million USD | -31.95% |
| 2004 | -56.16 Million USD | 14.82% |
| 2003 | -65.93 Million USD | -18.0% |
| 2002 | -55.87 Million USD | 24.02% |
| 2001 | -73.54 Million USD | -57.38% |
| 2000 | -46.72 Million USD | -158.17% |
| 1999 | -18.1 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -61.88 Million USD | -33.69% |
| 2024 Q2 | -53.08 Million USD | 14.23% |
| 2023 FY | -245.76 Million USD | 9.49% |
| 2023 Q3 | -62.2 Million USD | 15.29% |
| 2023 Q2 | -73.43 Million USD | -8.23% |
| 2023 Q4 | -46.29 Million USD | 25.58% |
| 2023 Q1 | -67.84 Million USD | 30.34% |
| 2022 Q3 | -74.27 Million USD | -45.35% |
| 2022 Q1 | -63.46 Million USD | 3.12% |
| 2022 FY | -271.51 Million USD | -186.72% |
| 2022 Q4 | -97.39 Million USD | -31.13% |
| 2022 Q2 | -51.1 Million USD | 19.48% |
| 2021 FY | -94.69 Million USD | 60.57% |
| 2021 Q2 | -83.29 Million USD | -55.17% |
| 2021 Q1 | -53.67 Million USD | -42.73% |
| 2021 Q4 | -65.51 Million USD | -136.69% |
| 2021 Q3 | 178.55 Million USD | 314.37% |
| 2020 Q4 | -37.6 Million USD | 26.48% |
| 2020 Q2 | -47.48 Million USD | -6.28% |
| 2020 Q1 | -44.67 Million USD | -48.64% |
| 2020 FY | -240.13 Million USD | -61.02% |
| 2020 Q3 | -51.15 Million USD | -7.74% |
| 2019 Q3 | -45.47 Million USD | 10.19% |
| 2019 Q4 | -30.05 Million USD | 33.91% |
| 2019 Q1 | 18.5 Million USD | 138.75% |
| 2019 Q2 | -50.63 Million USD | -373.61% |
| 2019 FY | -149.13 Million USD | 6.61% |
| 2018 Q3 | -33.12 Million USD | -34.27% |
| 2018 FY | -159.69 Million USD | -32.31% |
| 2018 Q1 | -54.14 Million USD | -54.53% |
| 2018 Q2 | -24.67 Million USD | 54.43% |
| 2018 Q4 | -47.75 Million USD | -44.16% |
| 2017 Q3 | -36.84 Million USD | -16.17% |
| 2017 FY | -120.69 Million USD | 4.96% |
| 2017 Q1 | -17.1 Million USD | 34.53% |
| 2017 Q2 | -31.71 Million USD | -85.42% |
| 2017 Q4 | -35.03 Million USD | 4.9% |
| 2016 Q3 | -40.77 Million USD | -43.97% |
| 2016 Q2 | -28.32 Million USD | 10.88% |
| 2016 FY | -126.99 Million USD | -44.51% |
| 2016 Q4 | -26.12 Million USD | 35.93% |
| 2016 Q1 | -31.77 Million USD | -103.62% |
| 2015 FY | -87.88 Million USD | -106.85% |
| 2015 Q2 | -40.41 Million USD | -115.61% |
| 2015 Q1 | -18.74 Million USD | 27.85% |
| 2015 Q4 | -15.6 Million USD | -18.94% |
| 2015 Q3 | -13.12 Million USD | 67.53% |
| 2014 FY | -42.48 Million USD | -41.28% |
| 2014 Q4 | -25.97 Million USD | -220.35% |
| 2014 Q2 | -7.76 Million USD | -2068.16% |
| 2014 Q3 | -8.1 Million USD | -4.48% |
| 2014 Q1 | -358 Thousand USD | 93.8% |
| 2013 FY | -30.07 Million USD | -165.55% |
| 2013 Q4 | -5.77 Million USD | 21.07% |
| 2013 Q1 | -5.83 Million USD | -7.26% |
| 2013 Q3 | -7.31 Million USD | 34.31% |
| 2013 Q2 | -11.14 Million USD | -90.95% |
| 2012 Q1 | 6.76 Million USD | 212.41% |
| 2012 Q4 | -5.44 Million USD | 5.04% |
| 2012 FY | -11.32 Million USD | 51.35% |
| 2012 Q2 | -6.92 Million USD | -202.3% |
| 2012 Q3 | -5.72 Million USD | 17.25% |
| 2011 Q1 | -5.96 Million USD | -146.84% |
| 2011 Q3 | -5.53 Million USD | 3.87% |
| 2011 Q4 | -6.02 Million USD | -8.78% |
| 2011 FY | -23.27 Million USD | -6.25% |
| 2011 Q2 | -5.75 Million USD | 3.47% |
| 2010 FY | -21.9 Million USD | 27.74% |
| 2010 Q4 | -2.41 Million USD | 57.67% |
| 2010 Q3 | -5.7 Million USD | -14.8% |
| 2010 Q2 | -4.97 Million USD | 43.57% |
| 2010 Q1 | -8.81 Million USD | -573.83% |
| 2009 Q4 | 1.85 Million USD | 117.52% |
| 2009 Q3 | -10.61 Million USD | 12.2% |
| 2009 Q2 | -12.08 Million USD | -27.56% |
| 2009 Q1 | -9.47 Million USD | -280.2% |
| 2009 FY | -30.31 Million USD | -5.65% |
| 2008 Q2 | -11.95 Million USD | -7.98% |
| 2008 Q4 | 5.25 Million USD | 148.11% |
| 2008 Q1 | -11.07 Million USD | -48.41% |
| 2008 FY | -28.69 Million USD | 22.01% |
| 2008 Q3 | -10.93 Million USD | 8.55% |
| 2007 FY | -36.79 Million USD | 29.08% |
| 2007 Q4 | -7.45 Million USD | 30.84% |
| 2007 Q3 | -10.78 Million USD | -9.48% |
| 2007 Q2 | -9.85 Million USD | -13.29% |
| 2007 Q1 | -8.69 Million USD | 24.62% |
| 2006 Q4 | -11.53 Million USD | -4.67% |
| 2006 Q1 | -15.23 Million USD | 14.02% |
| 2006 Q2 | -14.08 Million USD | 7.52% |
| 2006 FY | -51.88 Million USD | 29.99% |
| 2006 Q3 | -11.02 Million USD | 21.77% |
| 2005 Q4 | -17.71 Million USD | -2.68% |
| 2005 Q2 | -21.12 Million USD | -17.36% |
| 2005 Q1 | -18 Million USD | -3.18% |
| 2005 Q3 | -17.25 Million USD | 18.33% |
| 2005 FY | -74.1 Million USD | -31.95% |
| 2004 Q4 | -17.44 Million USD | 5.56% |
| 2004 Q1 | -17.15 Million USD | 4.99% |
| 2004 Q2 | -3.08 Million USD | 82.03% |
| 2004 FY | -56.16 Million USD | 14.82% |
| 2004 Q3 | -18.47 Million USD | -499.13% |
| 2003 Q3 | -17.76 Million USD | -6.91% |
| 2003 Q1 | -13.49 Million USD | 17.37% |
| 2003 Q2 | -16.61 Million USD | -23.18% |
| 2003 FY | -65.93 Million USD | -18.0% |
| 2003 Q4 | -18.05 Million USD | -1.62% |
| 2002 FY | -55.87 Million USD | 24.02% |
| 2002 Q4 | -16.32 Million USD | -20.45% |
| 2002 Q3 | -13.55 Million USD | 3.89% |
| 2002 Q2 | -14.1 Million USD | -18.64% |
| 2002 Q1 | -11.88 Million USD | 13.88% |
| 2001 Q2 | -8.42 Million USD | -15.3% |
| 2001 Q1 | -7.3 Million USD | 77.7% |
| 2001 FY | -73.54 Million USD | -57.38% |
| 2001 Q4 | -13.8 Million USD | 68.63% |
| 2001 Q3 | -44 Million USD | -422.3% |
| 2000 Q3 | -4.75 Million USD | 1.96% |
| 2000 Q1 | -4.36 Million USD | 0.0% |
| 2000 Q2 | -4.84 Million USD | -11.06% |
| 2000 Q4 | -32.76 Million USD | -589.75% |
| 2000 FY | -46.72 Million USD | -158.17% |
| 1999 FY | -18.1 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -67.872% |
| Alkermes plc | 355.75 Million USD | 169.081% |
| Aptorum Group Limited | -2.82 Million USD | -8600.592% |
| Ardelyx, Inc. | -66.06 Million USD | -271.988% |
| Dyadic International, Inc. | -6.79 Million USD | -3516.546% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -26156.517% |
| Lantern Pharma Inc. | -15.96 Million USD | -1439.708% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1191.516% |
| Novavax, Inc. | -545.06 Million USD | 54.911% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -321.596% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -233.055% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1225.136% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2361.055% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -316.666% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 34.223% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -909.729% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -558.171% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -49.332% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -235.066% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1111.182% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -294.765% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -656.537% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -85.49% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 44.176% |
| AlloVir, Inc. | -190.41 Million USD | -29.064% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -19.723% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -763.774% |
| Bicycle Therapeutics plc | -180.66 Million USD | -36.032% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -37.256% |
| ChromaDex Corporation | -4.93 Million USD | -4876.934% |
| Chimerix, Inc. | -82.09 Million USD | -199.362% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -450.993% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -140.777% |
| CRISPR Therapeutics AG | -153.61 Million USD | -59.99% |
| Precision BioSciences, Inc. | -61.31 Million USD | -300.791% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -52.715% |
| Fortress Biotech, Inc. | -60.63 Million USD | -305.299% |
| Fortress Biotech, Inc. | -60.63 Million USD | -305.299% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -201.252% |
| ImmuCell Corporation | -5.77 Million USD | -4155.898% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -117.563% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1493.156% |
| Incyte Corporation | 597.59 Million USD | 141.125% |
| Innoviva, Inc. | 179.72 Million USD | 236.745% |
| IO Biotech, Inc. | -86.08 Million USD | -185.493% |
| Jaguar Health, Inc. | -41.3 Million USD | -495.063% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -60.637% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 571.222% |
| ContextLogic Inc. | -317 Million USD | 22.473% |
| MiMedx Group, Inc. | 67.43 Million USD | 464.42% |
| MEI Pharma, Inc. | 17.77 Million USD | 1482.388% |
| NextCure, Inc. | -62.72 Million USD | -291.82% |
| Onconetix, Inc. | -37.4 Million USD | -556.945% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -522.511% |
| Opthea Limited | -220.24 Million USD | -11.587% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -380.386% |
| Vaxcyte, Inc. | -402.26 Million USD | 38.906% |
| PDS Biotechnology Corporation | -42.94 Million USD | -472.307% |
| Precigen, Inc. | -95.9 Million USD | -156.257% |
| Pharming Group N.V. | -10.54 Million USD | -2229.93% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -21.91% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -901.349% |
| PureTech Health plc | -65.69 Million USD | -274.083% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -879.479% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -15.805% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -909.729% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 4.681% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -802.273% |
| Acelyrin, Inc. | -381.64 Million USD | 35.604% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1959296.27% |
| Summit Therapeutics Inc. | -614.92 Million USD | 60.034% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -620.686% |
| Senti Biosciences, Inc. | -92.91 Million USD | -164.49% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -134.731% |
| Elevation Oncology, Inc. | -45.7 Million USD | -437.723% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -599.377% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1780.076% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -3576.305% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -737.004% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2790.966% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -327.314% |
| Seer, Inc. | -86.27 Million USD | -184.851% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -266.835% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -273.696% |
| ESSA Pharma Inc. | -26.58 Million USD | -824.527% |
| GlycoMimetics, Inc. | -36.89 Million USD | -566.029% |
| GT Biopharma, Inc. | -7.59 Million USD | -3134.974% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -1.823% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -373.3% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 444.155% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -351.584% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -400.328% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2370.519% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 57.098% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -6749.526% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -381.337% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -0.068% |
| Aptose Biosciences Inc. | -51.2 Million USD | -379.936% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -150.016% |
| Soligenix, Inc. | -6.14 Million USD | -3902.146% |
| Century Therapeutics, Inc. | -136.67 Million USD | -79.817% |
| Kura Oncology, Inc. | -152.63 Million USD | -61.016% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -175.461% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2232.141% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 43561.368% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -43091.74% |
| Autolus Therapeutics plc | -208.38 Million USD | -17.937% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -241.819% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -247.145% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1034.212% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -9.106% |
| GRI Bio, Inc. | -13.03 Million USD | -1785.104% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -5844.041% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -98.06% |
| IGM Biosciences, Inc. | -246.41 Million USD | 0.266% |
| INmune Bio, Inc. | -30 Million USD | -718.985% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -122.289% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -482.458% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1439.696% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1455.943% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -311.763% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -142.926% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 10.997% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -3.308% |
| Verastem, Inc. | -87.36 Million USD | -181.297% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -353.534% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -52.329% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -110.668% |
| Histogen Inc. | -10.62 Million USD | -2213.916% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1620.202% |
| Surrozen, Inc. | -43.04 Million USD | -470.98% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1575.148% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4731.13% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -369.557% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -872.81% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -812.321% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2840.75% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -62.664% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -402.311% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -726.782% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2259.071% |
| Apollomics, Inc. | -172.6 Million USD | -42.387% |
| Amarin Corporation plc | -59.11 Million USD | -315.755% |
| Mesoblast Limited | -87.95 Million USD | -179.414% |
| Turnstone Biologics Corp. | -55.2 Million USD | -345.219% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -67.228% |
| Synaptogenix, Inc. | -6.03 Million USD | -3969.899% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1416.294% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -214.997% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5029.14% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2824.962% |
| Exelixis, Inc. | 207.76 Million USD | 218.288% |
| Better Therapeutics, Inc. | -39.76 Million USD | -518.111% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -70.729% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 53.51% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1919.064% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -3052.928% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -699.249% |
| Gritstone bio, Inc. | -138.49 Million USD | -77.458% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -281.232% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -6044.102% |
| Avid Bioservices, Inc. | -140.75 Million USD | -74.604% |
| Insmed Incorporated | -749.56 Million USD | 67.213% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1517.966% |
| MediWound Ltd. | -6.71 Million USD | -3559.336% |
| OmniAb, Inc. | -50.61 Million USD | -385.511% |
| Alector, Inc. | -130.39 Million USD | -88.48% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -116.103% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -374.012% |
| Zai Lab Limited | -334.62 Million USD | 26.555% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 24.145% |
| Aura Biosciences, Inc. | -76.4 Million USD | -221.643% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -4.743% |
| Immunic, Inc. | -93.61 Million USD | -162.532% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -80.849% |
| Veracyte, Inc. | -74.4 Million USD | -230.306% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -3101.868% |
| FibroGen, Inc. | -284.23 Million USD | 13.535% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -836.875% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3409.924% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1204.97% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 159.244% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -989.608% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 598.794% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2039.402% |
| Galecto, Inc. | -38.34 Million USD | -540.854% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1202.666% |
| Fortrea Holdings Inc. | -3.4 Million USD | -7128.265% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -94.057% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1311.527% |
| XBiotech Inc. | -24.55 Million USD | -900.778% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -281.232% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -292.088% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -149.691% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1046.969% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -345.276% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 59.488% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -260.063% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -431559.465% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -8.485% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1003.675% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -11.857% |
| NexImmune, Inc. | -32.34 Million USD | -659.826% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -4548.776% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1649.7% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 106.216% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -914.661% |
| Scopus BioPharma Inc. | -11.6 Million USD | -2016.836% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -110.415% |
| Ainos, Inc. | -13.77 Million USD | -1684.686% |
| Pluri Inc. | -20.88 Million USD | -1076.565% |
| Prothena Corporation plc | -147.02 Million USD | -67.153% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -115.824% |
| Celularity Inc. | -196.29 Million USD | -25.2% |
| Rallybio Corporation | -74.56 Million USD | -229.597% |
| Cue Biopharma, Inc. | -50.73 Million USD | -384.42% |
| MeiraGTx Holdings plc | -84.02 Million USD | -192.479% |
| Omeros Corporation | -117.81 Million USD | -108.603% |
| Humacyte, Inc. | -110.77 Million USD | -121.854% |
| Immunocore Holdings plc | -55.28 Million USD | -344.519% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1266.554% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -971.741% |
| Blueprint Medicines Corporation | -506.98 Million USD | 51.525% |
| CalciMedica, Inc. | -34.35 Million USD | -615.316% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -263.149% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -73.799% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -48.237% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 13.237% |
| Pulmatrix, Inc. | -14.12 Million USD | -1640.394% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -598.284% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -197.395% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 48.927% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -134.346% |
| Cytokinetics, Incorporated | -526.24 Million USD | 53.299% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -581.439% |
| Nutriband Inc. | -5.48 Million USD | -4380.345% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -508.018% |
| Vor Biopharma Inc. | -117.86 Million USD | -108.514% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 105.651% |
| Evogene Ltd. | -23.87 Million USD | -929.193% |
| ProKidney Corp. | -35.46 Million USD | -592.909% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -105.206% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -3032.553% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 61.791% |
| CorMedix Inc. | -46.33 Million USD | -430.352% |
| BioLineRx Ltd. | -60.61 Million USD | -305.453% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -141.548% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -498.454% |
| Atai Life Sciences N.V. | -40.22 Million USD | -510.981% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -204.725% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -225.421% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 15.89% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -781.622% |
| MediciNova, Inc. | -8.57 Million USD | -2767.182% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -99.357% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2833.817% |
| GeoVax Labs, Inc. | -25.96 Million USD | -846.445% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -2.727% |
| Biomea Fusion, Inc. | -117.25 Million USD | -109.595% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 60.779% |
| Mereo BioPharma Group plc | -29.46 Million USD | -734.049% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -60.458% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -17.387% |
| Absci Corporation | -110.56 Million USD | -122.275% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -715.128% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -143.721% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -4.164% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1844.966% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -27.362% |
| Allakos Inc. | -185.7 Million USD | -32.342% |
| Imunon, Inc. | -19.51 Million USD | -1159.346% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -152.49% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 331.544% |
| BioAtla, Inc. | -123.46 Million USD | -99.058% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1919.064% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1428.555% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 24.905% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -565.136% |
| XOMA Corporation | -40.83 Million USD | -501.898% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -141.25% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -107.37% |
| aTyr Pharma, Inc. | -50.38 Million USD | -387.727% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -180.296% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -61.942% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -3.376% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -599.795% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -2937.109% |
| Akari Therapeutics, Plc | -10 Million USD | -2355.645% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -364936.762% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 187.275% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3587.393% |
| UroGen Pharma Ltd. | -102.24 Million USD | -140.367% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -130.128% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -3060.026% |
| Orgenesis Inc. | -55.36 Million USD | -343.924% |
| Entera Bio Ltd. | -8.88 Million USD | -2664.777% |
| GH Research PLC | -35.58 Million USD | -590.592% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1079.275% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -217.57% |
| Xencor, Inc. | -126.08 Million USD | -94.914% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -6426.3% |
| Replimune Group, Inc. | -215.79 Million USD | -13.887% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1055.623% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 9895.177% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3587.393% |
| Portage Biotech Inc. | -75.33 Million USD | -226.207% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2833.817% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -154.266% |
| OncoCyte Corporation | -27.78 Million USD | -784.637% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1731.685% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2109.779% |
| Purple Biotech Ltd. | -19.88 Million USD | -1136.222% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3401.368% |
| scPharmaceuticals Inc. | -54.81 Million USD | -348.387% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1303.856% |
| HilleVax, Inc. | -123.56 Million USD | -98.89% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2331.592% |
| Tharimmune, Inc. | -9.31 Million USD | -2537.177% |
| Genprex, Inc. | -30.86 Million USD | -696.362% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -4.169% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -716.645% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -13691.302% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -4540.489% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1460549.516% |
| Savara Inc. | -54.69 Million USD | -349.305% |
| Curis, Inc. | -47.41 Million USD | -418.341% |
| Daré Bioscience, Inc. | -30.16 Million USD | -714.82% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1491.192% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -4313.018% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -724.286% |
| BeiGene, Ltd. | -881.7 Million USD | 72.127% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1054.133% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 43.68% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -211.267% |
| Erasca, Inc. | -125.04 Million USD | -96.543% |
| bluebird bio, Inc. | -211.91 Million USD | -15.973% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4814.731% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 246.596% |
| DBV Technologies S.A. | -72.72 Million USD | -237.927% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4814.731% |
| Moderna, Inc. | -4.71 Billion USD | 94.787% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -512.0% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -4216.14% |
| Molecular Templates, Inc. | -8.12 Million USD | -2925.123% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -306.97% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -120.613% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -81.572% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -412.868% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -73.77% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -27.728% |
| MacroGenics, Inc. | -9.05 Million USD | -2613.193% |
| RenovoRx, Inc. | -10.23 Million USD | -2301.886% |
| Adicet Bio, Inc. | -142.65 Million USD | -72.273% |
| Prime Medicine, Inc. | -198.13 Million USD | -24.038% |
| Aditxt, Inc. | -32.38 Million USD | -658.97% |
| Adagene Inc. | -18.94 Million USD | -1197.14% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3261.191% |
| Quantum-Si incorporated | -95.96 Million USD | -156.108% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -106.472% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1585.862% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 285.718% |
| SciSparc Ltd. | -5.12 Million USD | -4698.145% |
| Vericel Corporation | -3.18 Million USD | -7623.476% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -204268.254% |
| Minerva Neurosciences, Inc. | -30 Million USD | -719.057% |
| Generation Bio Co. | -126.61 Million USD | -94.106% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -237.162% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -198.102% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 6.248% |
| Invivyd, Inc. | -198.64 Million USD | -23.72% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 28.134% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2729.205% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1177.616% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2388.971% |
| 2seventy bio, Inc. | -217.57 Million USD | -12.957% |
| ADMA Biologics, Inc. | -28.23 Million USD | -770.289% |
| Clene Inc. | -49.5 Million USD | -396.447% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1002.683% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -397.15% |
| GeoVax Labs, Inc. | -25.96 Million USD | -846.445% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 25.088% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -655.191% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1181.695% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -148.767% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -228.76% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -52.832% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 60.043% |
| Evaxion Biotech A/S | -22.12 Million USD | -1010.784% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -204.401% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -22.839% |
| Trevena, Inc. | -40.28 Million USD | -509.995% |
| Surrozen, Inc. | -43.04 Million USD | -470.98% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -255.485% |
| Cingulate Inc. | -23.53 Million USD | -944.239% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -3455.57% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -516.56% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -3087.283% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -172.432% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -301.007% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -313.023% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1955.712% |
| Kronos Bio, Inc. | -112.67 Million USD | -118.119% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -255.161% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -9689912.341% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -186.118% |
| Statera Biopharma, Inc. | -174.4 Million USD | -40.911% |
| ImmunityBio, Inc. | -583.19 Million USD | 57.86% |
| Korro Bio, Inc. | -81.17 Million USD | -202.766% |
| Kineta, Inc. | -14.09 Million USD | -1643.109% |
| BioVie Inc. | -32.12 Million USD | -665.121% |
| Codexis, Inc. | -76.24 Million USD | -222.352% |
| Celularity Inc. | -196.29 Million USD | -25.2% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -14.558% |
| Celcuity Inc. | -63.77 Million USD | -285.331% |
| Virax Biolabs Group Limited | -6.73 Million USD | -3549.805% |
| Cibus, Inc. | -267.62 Million USD | 8.17% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -509.436% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -586.272% |
| IN8bio, Inc. | -30 Million USD | -719.012% |
| Kodiak Sciences Inc. | -260.49 Million USD | 5.655% |
| Annexon, Inc. | -134.23 Million USD | -83.08% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -109.756% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -301.387% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -679.105% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 32.905% |
| Eyenovia, Inc. | -27.26 Million USD | -801.508% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1238.257% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -45836.636% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -221.66% |
| Arcellx, Inc. | -70.69 Million USD | -247.66% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -493.038% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -83.656% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -718.194% |
| Moolec Science SA | -51.78 Million USD | -374.544% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -369.269% |
| Geron Corporation | -184.12 Million USD | -33.474% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -485.508% |
| Royalty Pharma plc | 1.13 Billion USD | 121.656% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -80.765% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2663.905% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1056.891% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -43.159% |
| Humacyte, Inc. | -110.77 Million USD | -121.854% |
| Structure Therapeutics Inc. | -89.62 Million USD | -174.226% |
| 89bio, Inc. | -142.18 Million USD | -72.841% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -256.382% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2268.324% |
| Genelux Corporation | -28.29 Million USD | -768.505% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -745.557% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -38.755% |
| Notable Labs, Ltd. | -11.26 Million USD | -2081.827% |
| Liquidia Corporation | -78.5 Million USD | -213.063% |
| Mustang Bio, Inc. | -51.6 Million USD | -376.263% |
| Immunovant, Inc. | -259.33 Million USD | 5.235% |
| Quantum-Si incorporated | -95.96 Million USD | -156.108% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -237.357% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1168.051% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -156.028% |
| Acasti Pharma Inc. | -12.85 Million USD | -1812.091% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -994.321% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1439.696% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -34.743% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -5613.356% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1870.818% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -733.342% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -530.35% |
| PepGen Inc. | -78.62 Million USD | -212.57% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -725.56% |
| United Therapeutics Corporation | 984.8 Million USD | 124.955% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1004.048% |
| Solid Biosciences Inc. | -96.01 Million USD | -155.961% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5029.14% |
| Immuneering Corporation | -53.47 Million USD | -359.61% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4731.13% |
| Silo Pharma, Inc. | -3.7 Million USD | -6540.963% |
| Belite Bio, Inc | -31.63 Million USD | -676.938% |
| XOMA Corporation | -40.83 Million USD | -501.898% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -352.057% |
| Bionomics Limited | -15.49 Billion USD | 98.414% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -192.625% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -742.889% |
| uniQure N.V. | -308.47 Million USD | 20.331% |
| Cassava Sciences, Inc. | -97.21 Million USD | -152.796% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3261.191% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -99.11% |
| Forte Biosciences, Inc. | -31.47 Million USD | -680.789% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -2896.463% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -745.469% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -45836.636% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -836.875% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1390.816% |
| Altimmune, Inc. | -88.44 Million USD | -177.862% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -62.129% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -742.889% |
| Compugen Ltd. | -18.75 Million USD | -1210.446% |
| Peak Bio, Inc. | -1259.26 USD | -19516203.226% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -433.695% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1029.884% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 27.459% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -196.262% |
| Zura Bio Limited | -60.36 Million USD | -307.159% |
| PolyPid Ltd. | -23.86 Million USD | -929.797% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1462.173% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -196.262% |
| Instil Bio, Inc. | -156.08 Million USD | -57.451% |
| argenx SE | -295.05 Million USD | 16.706% |
| Immunome, Inc. | -106.8 Million USD | -130.1% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -478.343% |
| Verona Pharma plc | -54.36 Million USD | -352.024% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -145.965% |
| Shattuck Labs, Inc. | -87.29 Million USD | -181.52% |
| CervoMed Inc. | -2.17 Million USD | -11215.625% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -97.159% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1745.607% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -464.254% |
| Moolec Science SA | -51.78 Million USD | -374.544% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1421163.228% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -81.887% |
| AnaptysBio, Inc. | -163.61 Million USD | -50.203% |
| Design Therapeutics, Inc. | -66.86 Million USD | -267.565% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -201.866% |
| NeurAxis, Inc. | -14.62 Million USD | -1580.224% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -548.754% |
| Lumos Pharma, Inc. | -34.03 Million USD | -622.104% |
| Achilles Therapeutics plc | -69.66 Million USD | -252.775% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -145.965% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1132.805% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 8268.101% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -9689912.341% |
| Nutriband Inc. | -5.48 Million USD | -4380.345% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -144.06% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -405.608% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -218.793% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -623.465% |
| MoonLake Immunotherapeutics | -36 Million USD | -582.532% |
| Palisade Bio, Inc. | -12.3 Million USD | -1898.057% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -483.423% |
| Beam Therapeutics Inc. | -132.52 Million USD | -85.442% |
| Neurogene Inc. | -36.31 Million USD | -576.711% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -50.391% |
| AEON Biopharma, Inc. | -52.55 Million USD | -367.617% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -150.401% |
| Sesen Bio, Inc. | -19.88 Million USD | -1135.974% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -243.318% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1863.905% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 44.653% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -120.283% |
| Athira Pharma, Inc. | -117.67 Million USD | -108.853% |
| Vaccinex, Inc. | -20.25 Million USD | -1113.575% |
| HCW Biologics Inc. | -24.99 Million USD | -883.269% |
| XOMA Corporation | -40.83 Million USD | -501.898% |
| Nektar Therapeutics | -276.05 Million USD | 10.974% |
| Arvinas, Inc. | -367.3 Million USD | 33.09% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -364936.762% |
| Merus N.V. | -154.93 Million USD | -58.618% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -152.249% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -683.052% |
| Rezolute, Inc. | -68.45 Million USD | -258.99% |
| Clene Inc. | -49.5 Million USD | -396.447% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1493.422% |
| BeyondSpring Inc. | -21.02 Million USD | -1068.843% |
| Synlogic, Inc. | -57.28 Million USD | -329.037% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1965.045% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2170.1% |
| Peak Bio, Inc. | -1259.26 USD | -19516203.226% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -557.678% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2348.088% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -71.742% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 24.405% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -5220.694% |
| MannKind Corporation | -11.93 Million USD | -1958.645% |
| Ikena Oncology, Inc. | -68.16 Million USD | -260.533% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1069.455% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -164.45% |
| Gossamer Bio, Inc. | -179.81 Million USD | -36.673% |
| CohBar, Inc. | -11.96 Million USD | -1954.494% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -853.005% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -715.128% |
| Legend Biotech Corporation | -518.25 Million USD | 52.579% |
| Mural Oncology plc | -207.44 Million USD | -18.469% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -98.011% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1243.711% |
| Disc Medicine, Inc. | -76.42 Million USD | -221.555% |
| Champions Oncology, Inc. | -7.27 Million USD | -3277.694% |
| REGENXBIO Inc. | -263.49 Million USD | 6.73% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2215.644% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -417.337% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -547.02% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -145.361% |
| Vaxart, Inc. | -82.46 Million USD | -198.019% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 73733.387% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -554.621% |
| Cellectis S.A. | -101.05 Million USD | -143.186% |
| Longeveron Inc. | -21.41 Million USD | -1047.719% |
| Repare Therapeutics Inc. | -93.79 Million USD | -162.017% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 54.147% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -245.32% |
| Revolution Medicines, Inc. | -436.36 Million USD | 43.68% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -3640.085% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -697.304% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -254.465% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -279.659% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2404.954% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 106.79% |
| Denali Therapeutics Inc. | -145.22 Million USD | -69.229% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -204268.254% |
| Veru Inc. | -93.15 Million USD | -163.826% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -809.249% |
| Cingulate Inc. | -23.53 Million USD | -944.239% |
| Passage Bio, Inc. | -102.06 Million USD | -140.796% |
| Context Therapeutics Inc. | -23.96 Million USD | -925.533% |
| Exicure, Inc. | -16.91 Million USD | -1353.003% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -30.089% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -550.781% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -3676.683% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -33.075% |
| Nuvalent, Inc. | -126.21 Million USD | -94.71% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2237.096% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -182.877% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -704.613% |
| OmniAb, Inc. | -50.61 Million USD | -385.511% |
| Anew Medical, Inc. | 1.34 Million USD | 18356.923% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1431.698% |
| Lipocine Inc. | -16.35 Million USD | -1402.934% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -270.155% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -285.962% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -482.458% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -412.354% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1139.277% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 54.614% |
| Ocugen, Inc. | -63.07 Million USD | -289.614% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -156.718% |
| Q32 Bio Inc. | -112.96 Million USD | -117.563% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1329.508% |
| Alumis Inc. Common Stock | -154.99 Million USD | -58.563% |
| Equillium, Inc. | -13.33 Million USD | -1742.977% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -307.118% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -2976.691% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1203.687% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -315.966% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -114.588% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1237.26% |
| Dominari Holdings Inc. | -22.88 Million USD | -974.036% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2834.665% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1113.635% |
| Bio-Techne Corporation | 168.1 Million USD | 246.195% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 30.199% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 290.73% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -101.721% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -547.779% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -118.179% |
| Nkarta, Inc. | -117.5 Million USD | -109.157% |
| BioCardia, Inc. | -11.57 Million USD | -2023.939% |
| Iterum Therapeutics plc | -38.37 Million USD | -540.486% |